Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Kenneth R. Chien, Alessandra Moretti and Karl-Ludwig Laugwitz
Unlocking the therapeutic potential of embryonic stem (ES) cells has remained a tantalizing but elusive goal. In their Perspective, Chien, Moretti and Laugwitz discuss new work (Fraidenraich et al.) showing that ES cells can rescue otherwise lethal cardiac defects in mouse embryos even when injected into the peritoneum of the mother prior to conception. The rescue effect is not due to differentiation of the ES cells into cardiac cells per se, but rather to their secretion of factors that act locally or at a distance via the maternal circulation to trigger proliferation of cardiac muscle cells in the mutant mouse embryos.
The authors are in the Institute of Molecular Medicine, University of California San Diego, La Jolla, CA 92037, USA. E-mail: kchien{at}ucsd.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
RESEARCH ARTICLES
Diego Fraidenraich, Elizabeth Stillwell, Elizabeth Romero, David Wilkes, Katia Manova, Craig T. Basson, and Robert Benezra (8 October 2004) Science306 (5694), 247.
[DOI: 10.1126/science.1102612] |Abstract »|Full Text »|PDF »|Supporting Online Material »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Human embryonic stem cell transplantation to repair the infarcted myocardium.
J. Leor, S. Gerecht, S. Cohen, L. Miller, R. Holbova, A. Ziskind, M. Shachar, M. S Feinberg, E. Guetta, and J. Itskovitz-Eldor (2007)
Heart
93, 1278-1284
|Abstract »|Full Text »|PDF »
Cardiac Regeneration: Materials Can Improve the Passive Properties of Myocardium, but Cell Therapy Must Do More.
G. R. Gaudette and I. S. Cohen (2006)
Circulation
114, 2575-2577
|Full Text »|PDF »
Potential Benefits of Co-transplanting Autologous Adult Stem Cells Together with Human Embryonic Stem Cells or Their Differentiated Derivatives.
B. C. Heng, H. Liu, and T. Cao (2005)
Ann. Clin. Lab. Sci.
35, 3-6
|Full Text »|PDF »